Bobcatbio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$5.34M
- Investors
-
9
Bobcatbio General Information
Description
Developer of cancer-specific immunotherapy designed to facilitate the treatment of solid tumors. The company's technology utilizes an adoptive cell therapy approach, macrophage engineering and cryopreservation to provide targeted tumoricidal immune responses, systemic tumor elimination and non-lymphodepleting therapy administration, enabling oncology healthcare providers to improve patient outcomes and reduce reliance on traditional treatments like chemotherapy and radiation.
Contact Information
Website
www.bobcatbio.comCorporate Office
- 1214 Research Boulevard
- Suite 2010
- Hummelstown, PA 17036
- United States
Corporate Office
- 1214 Research Boulevard
- Suite 2010
- Hummelstown, PA 17036
- United States
Bobcatbio Timeline
Bobcatbio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A1) | 25-Feb-2025 | $5.34M | Completed | Clinical Trials - Phase 1 | ||
| 6. Early Stage VC (Series A) | 14-Feb-2024 | Completed | Clinical Trials - Phase 1 | |||
| 5. Grant | 01-Jan-2024 | Completed | Clinical Trials - Phase 1 | |||
| 4. Accelerator/Incubator | 01-Sep-2023 | Completed | Clinical Trials - Phase 1 | |||
| 3. Grant | 01-Jul-2022 | Completed | Clinical Trials - Phase 1 | |||
| 2. Grant | 20-Dec-2024 | $2.4M | Completed | Pre-Clinical Trials | ||
| 1. Grant | 22-Sep-2021 | $400K | Completed | Pre-Clinical Trials |
Bobcatbio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Bobcatbio Comparisons
Industry
Financing
Details
Bobcatbio Competitors (6)
One of Bobcatbio’s 6 competitors is Verseau Therapeutics, a Venture Capital-Backed company based in Auburndale, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verseau Therapeutics | Venture Capital-Backed | Auburndale, MA | ||||
| Macrophage Therapeutics | Corporation | Dublin, OH | ||||
| ALX Oncology | Formerly VC-backed | South San Francisco, CA | ||||
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Gilead | Formerly VC-backed | Foster City, CA |
Bobcatbio Signals
Bobcatbio Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NuFund Venture Group | Angel Group | Minority | ||
| GRA Venture Fund | Venture Capital | Minority | ||
| SeedFolio | Venture Capital | Minority | ||
| BioAdvance Capital (Conshohocken) | Venture Capital | Minority | ||
| Bios Partners | Venture Capital | Minority |
Bobcatbio FAQs
-
When was Bobcatbio founded?
Bobcatbio was founded in 2020.
-
Where is Bobcatbio headquartered?
Bobcatbio is headquartered in Hummelstown, PA.
-
What is the size of Bobcatbio?
Bobcatbio has 7 total employees.
-
What industry is Bobcatbio in?
Bobcatbio’s primary industry is Drug Discovery.
-
Is Bobcatbio a private or public company?
Bobcatbio is a Private company.
-
What is the current valuation of Bobcatbio?
The current valuation of Bobcatbio is .
-
What is Bobcatbio’s current revenue?
The current revenue for Bobcatbio is .
-
How much funding has Bobcatbio raised over time?
Bobcatbio has raised $32.4M.
-
Who are Bobcatbio’s investors?
NuFund Venture Group, GRA Venture Fund, SeedFolio, BioAdvance Capital (Conshohocken), and Bios Partners are 5 of 9 investors who have invested in Bobcatbio.
-
Who are Bobcatbio’s competitors?
Verseau Therapeutics, Macrophage Therapeutics, ALX Oncology, Carisma Therapeutics, and Gilead are some of the 6 competitors of Bobcatbio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process